Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 13,881 | 13,185 | 12,958 | 11,929 | 13,154 |
| Operating Income | -13,881 | -13,185 | -12,958 | -11,929 | -13,154 |
| Interest Expense | 4,223 | 3,324 | 3,245 | 2,699 | 2,303 |
| Other Income | 394 | 251 | 170 | 70 | 14 |
| Pre-tax Income | -17,710 | -16,258 | -16,033 | -14,558 | -15,443 |
| Net Income Continuous | -17,710 | -16,188 | -16,033 | -14,558 | -15,443 |
| Net Income | $-17,710 | $-16,188 | $-16,033 | $-14,558 | $-15,443 |
| EPS Basic Total Ops | -0.50 | -0.58 | -0.60 | -0.54 | -0.58 |
| EPS Basic Continuous Ops | -0.50 | -0.58 | -0.60 | -0.54 | -0.58 |
| EPS Diluted Total Ops | -0.50 | -0.58 | -0.60 | -0.54 | -0.58 |
| EPS Diluted Continuous Ops | -0.50 | -0.58 | -0.60 | -0.54 | -0.58 |
| EBITDA(a) | $-13,861 | $-13,159 | $-12,931 | $-11,899 | $-13,123 |